In the DANCAVAS Trial, researchers found a remarkable reduction in death of any cause, and this might be a game changer in prevention of cardiovascular diseases.

In this interview, Axel Cosmus Pyndt Diederichsen MD and Clyde W. Yancy MD, MSc, MACC, FAHA, MACP, FHFSA, FASPC (Hon.) discuss ESC Late-Breaker: DANCAVAS: screening and intervention to prevent cardiovascular disease.

Related References:

• https://www.nejm.org/doi/full/10.1056/NEJMoa2208681
• https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehac488/6677139

Clinical Topics: Prevention

Keywords: ACCELLite, ESC Congress, ESC22, Primary Prevention, Secondary Prevention

< Back to Listings